Medicare General Information, Eligibility and Entitlement Manual (Pub. 100-01), Ch. 6 § 170.5
Disclosure of Claims Payment Information in Alcohol and Drug
170.5 - Disclosure of Claims Payment Information in Alcohol and Drug
Abuse Cases
(Rev. 1, 09-11-02)
The law requires providers to observe more stringent rules when disclosing medical
information for claims processing purposes from the records of alcohol and drug abuse
patients. Since the standard consent statement on the provider billing form is not
sufficient authority, under the law, to permit the provider to release information from the
records of alcohol or drug abuse patients, more explicit consent statements are required.
Providers that participate in Medicare and alcohol and drug abuse prevention and
treatment programs must obtain written consent in each alcohol or drug abuse case from
beneficiaries to release medical information. This written consent, which allows the
provider to disclose the records of the patient, must include all of the following:
•
The name of the organization (e.g., hospital name) that is to make the disclosure;
•
The name or title of the person or organization to which disclosure is to be made
(e.g., CMS, including the appropriate MAC, specified by name);
•
The name of the patient;
•
The purpose or need for the information to be disclosed (e.g., for processing a
claim for Medicare payment and for such evaluation of the treatment program as
is legally and administratively required in the overall conduct of the Medicare
program);
•
The specific extent or nature of information to be disclosed (e.g., all medical
records regarding the beneficiary's treatment, hospitalization, and/or outpatient
care including treatment for drug abuse or alcoholism);
•
A statement that the beneficiary may revoke their consent at any time to prohibit
disclosures on or after date or revocation;
•
A statement specifying a date (not to exceed 2 years), event, or condition upon
which consent expires without revocation;
•
The date on which the consent is signed; and
•
The signature of the patient or the signature of their authorized or legal
representative.
If the beneficiary wishes, the consent statement may be expanded to permit disclosure by
the provider to any other person, organization, or program (e.g., PRO), as appropriate.
Providers may also give authorization to CMS and its contractors to re-disclose specific
information to third party payers for complementary insurance purposes.
The provider keeps the consent statement with the patient's medical and other records.
The duration of the consent statement is not to exceed 2 years after which it must be
renewed by the beneficiary if further disclosures are necessary.